跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cymevene - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cymevene
Approved
STANDARD
Cymevene
Valdephram
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bf5544776ebe6dc2
Company
Valdephram
Type
Standard
Approval Details
Approval Id
bf5544776ebe6dc2
Drug Approval Philippines Name
Cymevene
Product Name
Cymevene
Registration Number
DR-XY16502
Brand Name
Cymevene
Generic Name
Ganciclovir (As Sodium)
Dosage Form
Sterile Powder For IV Infusion
Dosage Strength
500 mg
Manufacturer
Valdephram
Importer
Zuellig Pharma Corporation.
Distributor
Zuellig Pharma Corporation.
Issuance Date
24 January 2023
Expiry Date
24 January 2028
Pharmacologic Category
Anticytomegalovirus
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bf5544776ebe6dc2
Type
Standard
Back to Philippines FDA Approvals